Bidisciplinary dermatology-pharmacovigilance consultations: Results of a two-year study

Ann Dermatol Venereol. 2022 Dec 7;S0151-9638(22)00097-7. doi: 10.1016/j.annder.2022.08.011. Online ahead of print.

Authors

P Sanchez-Pena¹, B Milpied², A-S Darrigade², G Miremont-Salamé³, A Pariente³, M Beylot Barry²

Affiliations

¹ Pharmacovigilance center, University Hospital of Bordeaux, Bordeaux, France. Electronic address: paola.sanchez-pena@u-bordeaux.fr.
² Dermatology Department, University Hospital of Bordeaux, Bordeaux, France.
³ Pharmacovigilance center, University Hospital of Bordeaux, Bordeaux, France; Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France.

PMID: 36496263
DOI: 10.1016/j.annder.2022.08.011

No abstract available

Keywords: Acute generalised exanthematous pustulosis; Cutaneous adverse-drug reaction; DRESS syndrome; Exanthema; Pharmacovigilance.

Publication types

Letter